Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.12 - $1.57 $491,189 - $688,542
438,562 New
438,562 $649,000
Q3 2023

Nov 14, 2023

BUY
$1.07 - $1.39 $38,538 - $50,063
36,017 New
36,017 $38,000
Q1 2023

May 15, 2023

BUY
$1.25 - $2.0 $215,913 - $345,462
172,731 New
172,731 $228,000
Q4 2021

Feb 14, 2022

SELL
$2.36 - $3.57 $163,363 - $247,122
-69,222 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$3.5 - $4.5 $242,277 - $311,499
69,222 New
69,222 $251,000
Q3 2020

Nov 16, 2020

SELL
$1.78 - $4.13 $48,601 - $112,765
-27,304 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$1.41 - $2.05 $38,498 - $55,973
27,304 New
27,304 $50,000
Q4 2019

Feb 14, 2020

SELL
$1.6 - $2.43 $1.13 Million - $1.72 Million
-709,026 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$1.63 - $2.62 $876,185 - $1.41 Million
-537,537 Reduced 43.12%
709,026 $1.33 Million
Q2 2019

Aug 14, 2019

BUY
$2.02 - $2.61 $202,335 - $261,433
100,166 Added 8.74%
1,246,563 $3.25 Million
Q1 2019

May 14, 2019

BUY
$2.0 - $2.65 $1.62 Million - $2.15 Million
810,228 Added 241.02%
1,146,397 $2.95 Million
Q4 2018

Feb 14, 2019

BUY
$2.08 - $3.36 $421,767 - $681,317
202,773 Added 152.01%
336,169 $773,000
Q3 2018

Nov 14, 2018

BUY
$2.6 - $3.59 $284,674 - $393,069
109,490 Added 458.0%
133,396 $428,000
Q2 2018

Aug 14, 2018

BUY
$2.83 - $4.11 $67,653 - $98,253
23,906 New
23,906 $68,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.